
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
The mother of a four-year-old with eczema discovered Eucerin Dry Skin treatment after trying a number of treatments in an attempt to clear up her daughter's cracked skin.